Impact of bladder-derived acellular matrix, growth factors, and extracellular matrix constituents on the survival and multipotency of marrow-derived mesenchymal stem cells

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 1, 2012, Pages 72-83

  Antoon, Roula ^a,b,c   Yeger, Herman ^a,c,d   Loai, Yasir ^a,b   Islam, Syed ^a   Farhat, Walid A ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

acellular matrix (ACM); BM MSC; growth factors; SMC; urinary bladder

Indexed keywords

BM-MSC; GROWTH FACTORS; MATRIX; SMC; URINARY BLADDER;

BONE; COLLAGEN; FLOWCHARTING; ORGANIC ACIDS; PEPTIDES; RATING; STEM CELLS; SUBSTRATES; TISSUE;

CELL CULTURE;

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FAT; GROWTH FACTOR; HYALURONIC ACID; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BLADDER; BONE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PROTEIN EXPRESSION; SWINE; WESTERN BLOTTING;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN TYPE I; COLLAGEN TYPE IV; CULTURE MEDIA; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; MESENCHYMAL STEM CELLS; MICE; MICROFILAMENT PROTEINS; MULTIPOTENT STEM CELLS; MYOCYTES, SMOOTH MUSCLE; MYOSIN HEAVY CHAINS; PHENOTYPE; PLASTICS; PROTO-ONCOGENE PROTEINS C-SIS; SUS SCROFA; TRANSFORMING GROWTH FACTOR BETA1; URINARY BLADDER;

EID: 81855194110     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33230     Document Type: Article

References (42)

1. Atala A,. Tissue engineering for bladder substitution. World J Urol 2000; 18: 364-370.
2. Kaefer M, Hendren WH, Bauer SB, Goldenblatt P, Peters CA, Atala A, Retik AB,. Reservoir calculi: A comparison of reservoirs constructed from stomach and other enteric segments. J Urol 1998; 160 (6 Pt 1): 2187-2190.
3. Shokeir AA,. Bladder regeneration: Between the idea and reality. BJU Int 2002; 89: 186-193.
4. Oberpenning F, Meng J, Yoo JJ, Atala A,. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 1999; 17: 149-155.
5. Yoo JJ, Meng J, Oberpenning F, Atala A,. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 1998; 51: 221-225.
6. Jayo MJ, Jain D, Wagner BJ, Bertram TA,. Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies. J Urol 2008; 180: 392-397.
7. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB,. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-1246.
8. Bianco P, Gehron Robey P,. Marrow stromal stem cells. J Clin Invest 2000; 105: 1663-1668.
9. Galmiche MC, Koteliansky VE, Briere J, Herve P, Charbord P,. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993; 82: 66-76.
10. Hegner B, Weber M, Dragun D, Schulze-Lohoff E,. Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells. J Hypertens 2005; 23: 1191-1202.
11. Remy-Martin JP, Marandin A, Challier B, Bernard G, Deschaseaux M, Herve P, Wei Y, Tsuji T, Auerbach R, Dennis JE, Moore KA, Greenberger JS, Charbord P., Vascular smooth muscle differentiation of murine stroma: A sequential model. Exp Hematol 1999; 27: 1782-1795.
12. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC,. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174: 11-20.
13. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD,. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93-98.
14. Fukuda K,. Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit Anom (Kyoto) 2002; 42: 1-9.
15. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK,. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40: 1275-1284.
16. Chung SY, Krivorov NP, Rausei V, Thomas L, Frantzen M, Landsittel D, Kang YM, Chon CH, Ng CS, Fuchs GJ,. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol 2005; 174: 353-359.
17. Kanematsu A, Yamamoto S, Iwai-Kanai E, Kanatani I, Imamura M, Adam RM, Tabata Y, Ogawa O,. Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 2005; 166: 565-573.
18. Shukla D, Box GN, Edwards RA, Tyson DR,. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008; 26: 341-349.
19. Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP,. Growth of bone marrow stromal cells on small intestinal submucosa: An alternative cell source for tissue engineered bladder. BJU Int 2005; 96: 1120-1125.
20. Ross JJ, Hong Z, Willenbring B, Zeng L, Isenberg B, Lee EH, Reyes M, Keirstead SA, Weir EK, Tranquillo RT, Verfaillie CM., Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 2006; 116: 3139-3149.
21. Narita Y, Yamawaki A, Kagami H, Ueda M, Ueda Y,. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res 2008; 333: 449-459.
22. Farhat WA, Chen J, Haig J, Antoon R, Litman J, Sherman C, Derwin K, Yeger H,. Porcine bladder acellular matrix (ACM): Protein expression, mechanical properties. Biomed Mater 2008; 3: 25015.
23. Farhat WA, Chen J, Sherman C, Cartwright L, Bahoric A, Yeger H,. Impact of fibrin glue and urinary bladder cell spraying on the in-vivo acellular matrix cellularization: A porcine pilot study. Can J Urol 2006; 13: 3000-3008.
24. Collier JH, Camp JP, Hudson TW, Schmidt CE,. Synthesis and characterization of polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications. J Biomed Mater Res 2000; 50: 574-584.
25. Slevin M, Kumar S, Gaffney J,. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277: 41046-41059.
26. Horwitz EM, Keating A,. Nonhematopoietic mesenchymal stem cells: What are they? Cytotherapy 2000; 2: 387-388.
27. da Silva Meirelles L, Caplan AI, Nardi NB,. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-2299.
28. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC,. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004; 78: 83-88.
29. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG,. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100: 8407-8411.
30. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K,. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-96.
31. Lu J, Landerholm TE, Wei JS, Dong XR, Wu SP, Liu X, Nagata K, Inagaki M, Majesky MW,. Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol 2001; 240: 404-418.
32. Hirschi KK, Rohovsky SA, D'Amore PA,. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-814.
33. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM,. Smooth muscle progenitor cells in human blood. Circulation 2002; 106: 1199-1204.
34. Roelen BA, Dijke P,. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003; 8: 740-748.
35. Chen G, Khalil N,. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res 2006; 7: 2.
36. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E,. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 1999; 274: 27161-27167.
37. Runyan CE, Schnaper HW, Poncelet AC,. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 2004; 279: 2632-2639.
38. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K,. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 2001; 89: 251-258.
39. Lien SC, Usami S, Chien S, Chiu JJ,. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal 2006; 18: 1270-1278.
40. Wang T, Xu Z, Jiang W, Ma A,. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol 2006; 109: 74-81.
41. Kobayashi N, Yasu T, Ueba H, Sata M, Hashimoto S, Kuroki M, Saito M, Kawakami M,. Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 2004; 32: 1238-1245.
42. Wallis MC, Yeger H, Cartwright L, Shou Z, Radisic M, Haig J, Suoub M, Antoon R, Farhat WA,. Feasibility study of a novel urinary bladder bioreactor. Tissue Eng Part A 2008; 14: 339-348.